» Articles » PMID: 34385323

P62-containing, Proteolytically Active Nuclear Condensates, Increase the Efficiency of the Ubiquitin-proteasome System

Overview
Specialty Science
Date 2021 Aug 13
PMID 34385323
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Degradation of a protein by the ubiquitin-proteasome system (UPS) is a multistep process catalyzed by sequential reactions. Initially, ubiquitin is conjugated to the substrate in a process mediated by concerted activity of three enzymes; the last of them-a ubiquitin ligase (E3)-belongs to a family of several hundred members, each recognizing a few specific substrates. This is followed by repeated addition of ubiquitin moieties to the previously conjugated one to generate a ubiquitin chain that serves as a recognition element for the proteasome, which then degrades the substrate. Ubiquitin is recycled via the activity of deubiquitinating enzymes (DUBs). It stands to reason that efficiency of such a complex process would depend on colocalization of the different components in an assembly that allows the reactions to be carried out sequentially and processively. Here we describe nuclear condensates that are dynamic in their composition. They contain p62 as an essential component. These assemblies are generated by liquid-liquid phase separation (LLPS) and also contain ubiquitinated targets, 26S proteasome, the three conjugating enzymes, and DUBs. Under basal conditions, they serve as efficient centers for proteolysis of nuclear proteins (e.g., c-Myc) and unassembled subunits of the proteasome, suggesting they are involved in cellular protein quality control. Supporting this notion is the finding that such foci are also involved in degradation of misfolded proteins induced by heat and oxidative stresses, following recruitment of heat shock proteins and their associated ubiquitin ligase CHIP.

Citing Articles

p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Yang X, Cao X, Zhu Q Cancer Metastasis Rev. 2025; 44(1):33.

PMID: 39954143 PMC: 11829845. DOI: 10.1007/s10555-025-10250-w.


The Chemopreventive Effect of Ginsenoside Compound K Is Regulated by PARP-1 Hyperactivation, Which Is Promoted by p62-Dependent SIRT6 Degradation.

Kim S, Ki S, Hyeong S, Oh S Nutrients. 2025; 17(3).

PMID: 39940397 PMC: 11821008. DOI: 10.3390/nu17030539.


4-Hydroxy-2-nonenal causes nuclear accumulation of p62 by inhibiting Xpo1 and promoting the proteolytic pathway in the nucleus.

Kayama E, Baoshuo N, Tatsuno R, Nishi K, Mohammed E, Abiko Y PLoS One. 2025; 20(2):e0316558.

PMID: 39899539 PMC: 11790078. DOI: 10.1371/journal.pone.0316558.


Protein quality control machinery: regulators of condensate architecture and functionality.

Rajendran A, Castaneda C Trends Biochem Sci. 2025; 50(2):106-120.

PMID: 39755440 PMC: 11805624. DOI: 10.1016/j.tibs.2024.12.003.


Lysosomal damage triggers a p38 MAPK-dependent phosphorylation cascade to promote lysophagy via the small heat shock protein HSP27.

Gallagher E, Oloko P, Fitch T, Brown E, Spruce L, Holzbaur E Curr Biol. 2024; 34(24):5739-5757.e8.

PMID: 39541976 PMC: 11652224. DOI: 10.1016/j.cub.2024.10.061.


References
1.
Saudou F, Finkbeiner S, Devys D, Greenberg M . Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998; 95(1):55-66. DOI: 10.1016/s0092-8674(00)81782-1. View

2.
Isogai S, Morimoto D, Arita K, Unzai S, Tenno T, Hasegawa J . Crystal structure of the ubiquitin-associated (UBA) domain of p62 and its interaction with ubiquitin. J Biol Chem. 2011; 286(36):31864-74. PMC: 3173063. DOI: 10.1074/jbc.M111.259630. View

3.
Welcker M, Orian A, Jin J, Grim J, Grim J, Harper J . The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A. 2004; 101(24):9085-90. PMC: 428477. DOI: 10.1073/pnas.0402770101. View

4.
Berkers C, van Leeuwen F, Groothuis T, Peperzak V, van Tilburg E, Borst J . Profiling proteasome activity in tissue with fluorescent probes. Mol Pharm. 2007; 4(5):739-48. DOI: 10.1021/mp0700256. View

5.
Alberti S, Gladfelter A, Mittag T . Considerations and Challenges in Studying Liquid-Liquid Phase Separation and Biomolecular Condensates. Cell. 2019; 176(3):419-434. PMC: 6445271. DOI: 10.1016/j.cell.2018.12.035. View